New research shows benefits of exercise for first time in advanced lung cancer
Most people with lung cancer are unaware of the benefits of regular exercise, yet new…
Browsing: ESMO2018
Cancer trial shows treating the prostate with radiotherapy improves survival
Treating the prostate with radiotherapy alongside standard treatment led to an 11 per cent increase…
ESMO 2018: Women more prone to selected oesophagogastric cancer chemotherapy side-effects
Men and women may need to be treated differently – at least when it comes…
ESMO 2018: Oncologists demand more education on the use of biosimilars
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including…
ESMO 2018: Shorter-course trastuzumab could be an option in HER2 positive early breast cancers
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower…
ESMO 2018: One in six premenopausal early breast cancer patients do not adhere to hormonal therapy
Nearly one in six premenopausal women being treated for early stage breast cancer do not…
ESMO 2018: Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer
Epigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced…
ESMO 2018: New option for women with advanced breast cancer resistant to hormone therapy
Treatment with the cyclin dependent kinase (CDK) 4/6 inhibitor palbociclib achieves a clinically meaningful improvement…
ESMO 2018: Some patients with metastatic triple negative breast cancer live longer with immunotherapy
Immunotherapy improves survival in some patients with metastatic triple negative breast cancer, according to late-breaking…
ESMO 2018: Targeting specific genomic mutation in breast cancer improves outcomes, first study shows
Targeting a common mutation in patients with hormone receptor positive (HR ) HER2 negative (HER2-)…